Tata Elxsi to collaborate with Hemex Health for product design

Tata Elxsi announced that the company has been selected by Hemex Health as the product design and engineering partner of its latest Lab-in-a-Box diagnostic device, the company said in a filing to the bourses on Tuesday. 
 
Hemex Health is designing a cost-effective and easy-to-use, point-of-care device that helps health workers provide quick and accurate diagnosis of malaria and sickle cell disease. The Lab-in-a-Box diagnostic device can diagnose malaria and sickle cell disease in minutes. The new device integrates both malaria and sickle cell diagnostics inside a single unit.
 
According to statistics provided by the World Health Organization (WHO), it is estimated that up to 3.4 billion people (half the world’s population) are currently at risk for malaria, especially in developing countries.

On the other hand, sickle cell disease is genetic in nature and known to cause recurring long-term health issues such as anemia, bacterial infections, and stroke. As of 2015, it was estimated that up to 7% of the world’s population carry this gene. International agencies acknowledge that progress on these diseases is hampered by the lack of affordable diagnostics at the point of care.
 
Meanwhile, the stock was trading lower by 0.06% at Rs 1,727 per share on the BSE at 1128 hours.